Specialty drug pipeline predictions: Seven key areas to watch
The specialty drugs market will see more approvals in 2017 than 2016. Top areas to watch include cancer, multiple sclerosis, and HIV.
Read More
Monetary benefits from value-based diabetes plans take time
Value-based insurance designs for diabetes care improve outcomes, but monetary gains may take years.
Highly specific indications dominate cancer drug pipeline
Recent and pending drug approvals emphasize the growing importance of niche agents for very specific cancer patient populations.
Medicare Advantage vs. specialized Medicare Advantage plans: Outcome effects
Avalere Health analysis has intriguing results about beneficiaries enrolled in diabetes-focused chronic condition special needs plans.
Drug shortages likely after hurricanes
FDA Commissioner Scott Gottlieb, MD, said that the United States is likely to see shortages on certain drugs because after Hurricanes Irma and Maria knocked out power to the islands.
Many hospitals not sharing e-patient data
Why researchers say the industry is “a long way off” from robust electronic patient data sharing.
Trump’s steps to undo the ACA: Top takeaways from healthcare insiders
Trump takes two steps to dissolve the ACA. Find out what the experts think about these two important actions.
Five ways Trump’s efforts to strip the ACA will affect healthcare
Here’s a quick guide to the meaning behind Trump’s executive order and decision to stop cost-sharing reduction payments.
Five key focus areas for building a consumer-centric healthcare organization
Here’s how to take consumer-centricity more seriously as expectations increase.
FDA challenges abuse-deterrent opioid drug claim
The FDA pushes back on new painkiller’s abuse-deterrent claims. Here’s why this is important to the opioid epidemic.
Opinion: Four reasons Texas Health Aetna joint venture is working
As the industry moves to a value-based care model, here’s how one North Texas partnership is reinventing healthcare.
This is why you should be excited for upcoming cancer research
Acute myeloid leukemia experts share promising new developments on the oncology horizon.
Study: Patients combine toxic medications with ‘alarming frequency’
A new study uses population health analytics to identify potential opioid abuse, and the study findings are troubling.
Three Orphan Drug Program problems and how the FDA plans to fix them
Recently, FDA Commissioner Scott Gottlieb announced the FDA will move to close loopholes in the Orphan Drug Program. Here’s what you need to know.
Top factors that predict 30-day COPD readmissions
Recent study findings reveal which patients are more likely to be readmitted for COPD problems, and which readmission reduction strategies might work best.
Five ways health executives can impact the opioid crisis
Consider these five opportunities to help curb one of the biggest public health issues of the year.
COPD one of ‘most important’ diagnoses to manage in ACOs
To succeed as a Next Generation ACO, Indiana University Health system is changing its COPD care management approach.
Do antidepressants take more lives than they save?
An eye-opening Canadian study has surprising findings about the risk of death and antidepressants.
Pop health can decrease hypertension, diabetes: 3 takeaways
San Diego-area healthcare organizations experience promising results after using population health strategies to improve hypertension treatment across the region.
Health plan addresses urban vs. rural healthcare disparities
The access problems many rural health plan members face cannot be rectified overnight, but resources, creativity and time can bring these populations up to par with their more urban counterparts.
Payments to specialists could yo-yo under MIPS
Avalere conducted an analysis to assess the effect of MIPS. Here are the surprising results.
Four things payers need to know about acute myeloid leukemia
Physicians need to be able to move quickly to care for patients with AML, and they need to have payers on board.
Six ways to reduce hospital readmissions in 2018
Learn from hospitals and managed care organizations at the forefront of successful initiatives. Read more.
Top ways payers, providers use tech to improve care
How payers, providers are improving work flows, patient care, and cutting costs.
Six policy topics every healthcare executive needs to understand
New healthcare terms and topics constantly crop up. Here are six to keep an eye on right now.
New drug offers hope to advanced breast cancer patients
FDA approved a new treatment for certain breast cancer patients who are not responding to treatment.
Novel device helps diabetics avoid stress linked to glucose testing
FDA approved the first continuous glucose monitoring system that allows for diabetes treatment decisions without requiring a fingerstick.
How to meet unique health needs of LGBT individuals
Finding ways to communicate directly with and provide tailored services to LGBT individuals has been a challenge for managed care organizations, but experts say breaking barriers is imperative.
Pediatric drug market poised for growth
More support for clinical trials and a wider lens for rare diseases in children sets the category on fire.
Two opioid use disorder drug developments to watch
New physician-administered therapies on the horizon may help rein in the opioid epidemic.
